QUMAS Offers R&D Suite

QUMAS recently made its QUMAS R&D software suite available to biotechnology and pharmaceutical companies.

QUMAS provides regulatory affairs and quality management solutions, and the new research and development suite is the first of a series for the life sciences that will focus on drug quality and development.

“In their efforts to automate manual compliance processes, our customers have struggled with integrating and managing all the solution components they need to achieve their business goals,” says Kevin O’Leary, QUMAS CEO.

The QUMAS R&D suite assists life sciences companies to expedite the new drug application process with better quality submissions, fewer iterations, and shortened review and approval cycles. It addresses the integration of submissions and document management into one seamless life cycle.

“Conventional submission-management solutions are not enough,” says Ken Hayward, head of QUMAS’ life sciences division. “By combining content authoring, content management, real-time collaboration and submission management, we provide one integrated solution for all functional R&D areas. Companies can immediately realize streamlined regulatory submissions.”

For more information, visit www.qumas.com/news-events/pr-020507.asp.

About The Author